详情页

当前位置：首页 > 详情页

A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric Carcinoma

6| 链接全文 |

文献详情

编号/登记号：

注册时间：

研究开始时间：

研究结束时间：

项目类型：

本院角色：

多中心研究：

招募状态：

试验分期：

研究疾病/适应症：

研究类型：

研究参与人：

研究单位： [1]CSPC ZhongQi Pharmaceutical Technology Co., Ltd. [2]Fujian Cancer Hospital Fuzhou, Fujian, China, 350011 [3]Lanzhou University Second Hospital Lanzhou, Gansu, China, 730030 [4]Hebei General Hospital Shijiazhuang, Hebei, China, 050000 [5]The Fourth Hospital of Hebei Medical University and Hebei Cancer Hospital Shijiazhuang, Hebei, China, 050019 [6]Henan Cancer Hospital Zhengzhou, Henan, China, 450000 [7]Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China, 310014 [8]Cancer Hospital of The University of Chinese Academy of Science Hangzhou, Zhejiang, China, 310022 [9]Taizhou Hospital of Zhejiang Province Taizhou, Zhejiang, China, 317000 [10]Beijing Luhe Hospital Capital Medical University Beijing, Beijing, China, 101149

研究目的：

This is a multicenter, open-label, single-arm, phase Ib study to evaluate the safety and efficacy of Mitoxantrone Hydrochloride Liposome in subjects with advanced gastric carcinoma.